Needham analyst Mayank Tandon downgrades Duck Creek Technologies (NASDAQ:DCT) from Buy to Hold.
Needham Maintains Buy Rating for Collegium Pharmaceutical: Here’s What You Need To Know
Needham has decided to maintain its Buy rating of Collegium Pharmaceutical (NASDAQ:COLL) and raise its price target from…